U.S. markets closed

Grifols, S.A. (GRFS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.33-0.57 (-3.18%)
At close: 4:00PM EDT

17.33 0.00 (0.00%)
After hours: 4:00PM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close17.90
Open17.52
Bid17.31 x 3000
Ask17.32 x 1400
Day's Range17.26 - 17.72
52 Week Range13.40 - 25.73
Volume988,267
Avg. Volume1,580,464
Market Cap16.356B
Beta (5Y Monthly)0.20
PE Ratio (TTM)28.91
EPS (TTM)0.60
Earnings DateN/A
Forward Dividend & Yield0.44 (2.48%)
Ex-Dividend DateDec 02, 2019
1y Target Est25.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
-1% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • GRFS vs. ZTS: Which Stock Is the Better Value Option?
    Zacks

    GRFS vs. ZTS: Which Stock Is the Better Value Option?

    GRFS vs. ZTS: Which Stock Is the Better Value Option?

  • Schneider Electric and Aramco to Collaborate on O-PAS™ Automation Test Bed
    CNW Group

    Schneider Electric and Aramco to Collaborate on O-PAS™ Automation Test Bed

    * Companies will jointly assess and validate next-generation open and interoperable technologies * Aramco to enhance local capacity and readiness to execute pilot of advanced capabilities * Intrinsically cybersecure, interoperable automation technologies expected to bring step change improvements in operational flexibility, sustainability and efficiency MISSISSAUGA, ON, Oct. 28, 2020 /CNW/ - Schneider Electric, the leader in digital transformation of energy management and automation, and Aramco, the world's pre-eminent integrated energy and chemicals company that drives global commerce and enhances the daily lives of people around the globe, today announced they have signed a memorandum of understanding to collaborate on assessing emerging technologies based on the Open-Process Automation Standard (O-PAS).

  • Grifols' anti-SARS-CoV-2 hyperimmune globulin begins clinical trial in patients with COVID-19
    PR Newswire

    Grifols' anti-SARS-CoV-2 hyperimmune globulin begins clinical trial in patients with COVID-19

    Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global leader in the development of therapies with plasma-derived proteins with a track record of more than 100 years dedicated to enhancing people's health and well-being, today announced that its anti-SARS-CoV-2 hyperimmune globulin, a potential treatment for COVID-19, has started a randomized controlled clinical trial to test its safety, efficacy and tolerability. This medicine provides a high and consistent concentration of purified neutralizing antibodies and could be used for both prevention and treatment of the disease. The study is sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH).